Literature DB >> 8636367

The control of ovulation in mothers of dizygotic twins.

C P Gilfillan1, D M Robertson, H G Burger, M A Leoni, V A Hurley, N G Martin.   

Abstract

Dizygotic twinning is familial, suggesting that there may be an inherited abnormality of the control of ovulation that predisposes to double ovulation and, therefore, dizygotic twins. The present study examines 17 mothers of dizygotic twins (MODZT) and 8 control mothers of singletons by daily blood sampling throughout an entire menstrual cycle. Blood samples were assayed for LH, FSH, estradiol, progesterone, and inhibin. The process of follicular development was followed by transvaginal ultrasound. The pituitary LH response to iv GnRH was also assessed. Three of the 16 MODZT double ovulated during the study compared to none of the 8 control mothers (P < 0.05). The number of small follicles (<6 mm) declined significantly in control women at midcycle, but not in MODZT. There was no significant difference in serum FSH, LH, estradiol, or inhibin levels between the 2 groups at any stage of the menstrual cycle. During the follicular phase, serum progesterone levels were significantly higher in MODZT. The response to GnRH stimulation was not different between MODZT and controls. In conclusion, this study demonstrates an increased tendency to double ovulate in MODZT that may be due to a reduced rate of atresia in advanced follicles. Furthermore, the elevated progesterone levels in MODZT during the follicular phase suggest altered intrafollicular steroidogenesis that is independent of gonadotropins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636367     DOI: 10.1210/jcem.81.4.8636367

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  A genome wide linkage scan for dizygotic twinning in 525 families of mothers of dizygotic twins.

Authors:  Jodie N Painter; Gonneke Willemsen; Dale Nyholt; Chantal Hoekstra; David L Duffy; Anjali K Henders; Leanne Wallace; Sue Healey; Lisa A Cannon-Albright; Mark Skolnick; Nicholas G Martin; Dorret I Boomsma; Grant W Montgomery
Journal:  Hum Reprod       Date:  2010-04-08       Impact factor: 6.918

Review 2.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 3.  Genetic control of multiple births in low ovulating mammalian species.

Authors:  Aurélie Vinet; Laurence Drouilhet; Loys Bodin; Philippe Mulsant; Stéphane Fabre; Florence Phocas
Journal:  Mamm Genome       Date:  2012-08-08       Impact factor: 2.957

4.  Identification of Common Genetic Variants Influencing Spontaneous Dizygotic Twinning and Female Fertility.

Authors:  Hamdi Mbarek; Stacy Steinberg; Dale R Nyholt; Scott D Gordon; Michael B Miller; Allan F McRae; Jouke Jan Hottenga; Felix R Day; Gonneke Willemsen; Eco J de Geus; Gareth E Davies; Hilary C Martin; Brenda W Penninx; Rick Jansen; Kerrie McAloney; Jacqueline M Vink; Jaakko Kaprio; Robert Plomin; Tim D Spector; Patrik K Magnusson; Bruno Reversade; R Alan Harris; Kjersti Aagaard; Ragnar P Kristjansson; Isleifur Olafsson; Gudmundur Ingi Eyjolfsson; Olof Sigurdardottir; William G Iacono; Cornelis B Lambalk; Grant W Montgomery; Matt McGue; Ken K Ong; John R B Perry; Nicholas G Martin; Hreinn Stefánsson; Kari Stefánsson; Dorret I Boomsma
Journal:  Am J Hum Genet       Date:  2016-04-28       Impact factor: 11.025

5.  Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan.

Authors:  Asuka Morikawa; Kazu Ueda; Kazuaki Takahashi; Masaharu Fukunaga; Mitsutoshi Iwashita; Yoichi Kobayashi; Kimihiro Takechi; Satoshi Umezawa; Fumitoshi Terauchi; Kazushige Kiguchi; Daisuke Aoki; Hiroyuki Nomura; Hiroyuki Yoshikawa; Toyomi Satoh; Toshiko Jobo; Hiroyuki Fujiwara; Yuji Takei; Seiryu Kamoi; Yasuhisa Terao; Seiji Isonishi
Journal:  Int J Clin Oncol       Date:  2014-02-18       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.